Trial intelligence / Profile preview

Efficacy and Safety of Rotarix in Healthy Infants

NCT00139347Phase 3Completed

Sponsor
GSK
Start
Dec 2003
Primary completion
Mar 2007
Modality
Live Attenuated Vaccines
Countries
6
01

Overview

A Phase 3 trial of rotavirus vaccine, live, oral in rotavirus gastroenteritis, sponsored by GSK. Started Dec 2003; status: completed.

02

Drugs

rotavirus vaccine, live, oral
03

Conditions

rotavirus gastroenteritis

Beyond the preview

Go deeper on NCT00139347.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00139347.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call